Klinische Studie

ELUCIDATE FFRct Study

NCT: NCT06018194 · COMPLETED

NCT-IDNCT06018194

Medizinische Daten: StatusCOMPLETED

Startdatum2023-09-01

Abschluss2025-07-28

SponsorElucid Bioimaging Inc. (INDUSTRY)

First posted2023-08-30

Last updated2026-09-10

Kurzzusammenfassung

The goal of this study is to evaluate the diagnostic accuracy of a novel plaque-based coronary CT angiography (CCTA) fractional flow reserve (FFRct) software device for the estimation of invasive fractional flow reserve (FFR). Researchers will compare the Elucid plaque-based FFRct analysis to invasively measured FFR in patients who have previously undergone CCTA and invasively assessed FFR.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.